These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 19517313

  • 1. Drug Development for Neurodegenerative Diseases--a marcus evans conference. Expediting drugs to the market for neurodegenerative disease indications through novel translational efforts, regulatory clarity, and sound trial design. 7-8 April 2009, Boston, MA, USA.
    Morimoto B.
    IDrugs; 2009 Jun; 12(6):349-52. PubMed ID: 19517313
    [No Abstract] [Full Text] [Related]

  • 2. Drug Development for Neurodegenerative Diseases--Second Annual marcus evans Conference. Advances in drug development for NDD and expediting discovery through novel compounds and sound clinical trials.
    Morimoto B.
    IDrugs; 2010 Jul; 13(7):440-3. PubMed ID: 20582866
    [Abstract] [Full Text] [Related]

  • 3. Ocular Diseases & Drug Discovery--GTCbio's Inaugural Conference. 20-21 April 2009, Philadelphia, PA, USA.
    Boniuk V.
    IDrugs; 2009 Jun; 12(6):346-8. PubMed ID: 19517312
    [No Abstract] [Full Text] [Related]

  • 4. Society for Neuroscience - 39th Annual Meeting. Part 2 - Novel therapies for neurodegenerative disorders and other CNS diseases.
    Al-Shamahi A, Kirkham K, Hookes L.
    IDrugs; 2009 Dec; 12(12):734-7. PubMed ID: 19943211
    [Abstract] [Full Text] [Related]

  • 5. CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.
    Seneci P.
    IDrugs; 2009 Jun; 12(6):358-62. PubMed ID: 19517315
    [No Abstract] [Full Text] [Related]

  • 6. Clinical trials in CNS--SMi's eighth annual conference.
    Kirk R.
    IDrugs; 2010 Feb; 13(2):66-9. PubMed ID: 20127552
    [Abstract] [Full Text] [Related]

  • 7. Asthma and COPD--SMi's Fifth Annual Conference. 20-21 April 2009, London, UK.
    Macauley D.
    IDrugs; 2009 Jun; 12(6):342-5. PubMed ID: 19517311
    [Abstract] [Full Text] [Related]

  • 8. European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain.
    Wong NC.
    IDrugs; 2009 Nov; 12(11):675-8. PubMed ID: 19844849
    [Abstract] [Full Text] [Related]

  • 9. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
    Gale S, McGee V, Lee W.
    IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
    [No Abstract] [Full Text] [Related]

  • 10. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.
    Walker K, Padhiar M.
    IDrugs; 2010 Jan; 13(1):10-2. PubMed ID: 20024839
    [Abstract] [Full Text] [Related]

  • 11. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P.
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract] [Full Text] [Related]

  • 12. Neurodegenerative disorders and their treatment.
    Karran E, Palmer AM.
    Drug News Perspect; 2007 Jun; 20(6):407-12. PubMed ID: 17925895
    [Abstract] [Full Text] [Related]

  • 13. 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey.
    Ivachtchenko AV, Ivanenkov YA, Tkachenko SE.
    Expert Opin Ther Pat; 2010 Sep; 20(9):1171-96. PubMed ID: 20716023
    [Abstract] [Full Text] [Related]

  • 14. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1.
    Walker K, Padhiar M.
    IDrugs; 2010 Jan; 13(1):7-9. PubMed ID: 20024838
    [Abstract] [Full Text] [Related]

  • 15. Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological options.
    Tillement JP, Lecanu L, Papadopoulos V.
    Pharmacology; 2010 Jan; 85(1):1-17. PubMed ID: 19923873
    [Abstract] [Full Text] [Related]

  • 16. List of drugs in development for neurodegenerative diseases. Update June 2007.
    Pogacić V, Herrling P.
    Neurodegener Dis; 2007 Jan; 4(6):443-86. PubMed ID: 17934328
    [No Abstract] [Full Text] [Related]

  • 17. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
    Pogocki D, Ruman T, Danilczuk M, Danilczuk M, Celuch M, Wałajtys-Rode E.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):18-39. PubMed ID: 17376429
    [Abstract] [Full Text] [Related]

  • 18. Drug discovery and development for Huntington's disease - an orphan indication with high medical need.
    Heitz F, La Rosa S, Gonzalez-Couto E, Gaviraghi G, Terstappen GC.
    IDrugs; 2008 Sep 01; 11(9):653-60. PubMed ID: 18763216
    [Abstract] [Full Text] [Related]

  • 19. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
    Gale S, McGee V, Lee W.
    IDrugs; 2009 Jun 01; 12(6):335-8. PubMed ID: 19517309
    [No Abstract] [Full Text] [Related]

  • 20. Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK.
    Walker G.
    IDrugs; 2009 Nov 01; 12(11):673-4. PubMed ID: 19844848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.